National Centre for Cell Science
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
1
Ending by 2030
Jan 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 1, 2027The maintenance fee for Tumor deconstruction platform for the analysis of intra-tumor heterogeneity (US 10,429,393) comes due Apr 1, 2027. Unpaid by Oct 1, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,865,237 | Method of preparing dialysed extract of fenugreek seeds which induces hypoglycemia, mediated, in part, via stimulation of insulin signaling pathway In force · From the USPTO record | In force | From the USPTO record | |
| US 10,429,393 | Tumor deconstruction platform for the analysis of intra-tumor heterogeneity In force · From the USPTO record | In force | From the USPTO record | |
| US 11,478,532 | Therapeutic intervention for osteoporosis In force · From the USPTO record | In force | From the USPTO record | |
| US 12,544,347 | Novel Anti-Cancer Combination and a Method of Therapy Using the Combination In force · High confidence | In force | High confidence | |
| US 12,023,336 | Antiviral Drug Compounds and Composition Thereof In force · High confidence | In force | High confidence | |
| US 12,662,524 | Daf-Mcp Chimeric Proteins, Process to Manufacture the Same and Use of the Chimeric Protein for Treating Pathological Conditions Involving the Complement System In force · High confidence | In force | High confidence |
Also on record, not counted in the 6: 5 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 no status recorded